Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Correction of rectal sacculation through lateral resection in dogs with perineal hernia - technique description

The occurrence of perineal hernias in dogs during routine clinical surgery is frequent. The coexistence of rectal diseases that go undiagnosed or are not correctly treated can cause recurrence and postoperative complications. The objective of this report is to describe a surgical technique for treatment of rectal sacculation through lateral resection in dogs with perineal hernia, whereby restoring the rectal integrity.Universidade Estadual Julio de Mesquita filho UNESP-FCAV, Jaboticabal, SPPrograma de pós graduação Universidade Estadual Julio de Mesquita filho UNESP-FCAV, JaboticabalUniversidade Estadual Julio de Mesquita filho UNESP-FCAV, Jaboticabal, SPPrograma de pós graduação Universidade Estadual Julio de Mesquita filho UNESP-FCAV, Jaboticaba

Suplemento mineral aniônico para vacas no periparto: parâmetros sanguíneos, urinários e incidência de patologias de importância na bovinocultura leiteira

A fim de avaliar o efeito do suplemento mineral aniônico sobre parâmetros sanguíneos, urinários e incidência de hipocalcemia e retenção de placenta, dezoito vacas de aptidão leiteira com grau de sangue 7/8 Holandesa preta e branca, com 440-620 kg e 5-10 anos, foram divididas com delineamento em blocos em função da ordem de parto em dois grupos: controle (BCAD=46,38mEq/kg de MS) e tratamento (com adição de suplemento mineral aniônico e BCAD = -249,28mEq/kg de MS). Foram monitorados níveis de cálcio total e pH na urina e soro sanguíneo; TCO2, pCO2, HCO3, excesso de base, cálcio ionizado, Na, K, Se no sangue; escore de condição corporal, hematócrito e hemoglobina. Os dados sanguíneos, urinários e ECC foram submetidos ao Proc Means do SAS (2000) com análise de variância a 5% e teste de Tukey e a incidência de retenção de placenta analisada por Mann-Whitney (P<0,07) e a concentração sérica de Se por teste t de Student (P<0,05), ambos pelo GraphPad Prism 5.0. O suplemento mineral aniônico diminuiu os valores de TCO2, pCO2, HCO3 e EB no sangue com menor perda de peso, mas a variação de pH e cálcio foi restrita ao tempo. O suplemento mineral aniônico não provocou leve acidose metabólica desejada e, consequentemente, não preveniu a hipocalcemia. Contudo, por apresentar Se em sua composição, proporcionou maior concentração deste micronutriente no soro e contribuiu para menor retenção de placenta